Nature Communications (May 2023)

Re-convolving the compositional landscape of primary and recurrent glioblastoma reveals prognostic and targetable tissue states

  • Osama Al-Dalahmah,
  • Michael G. Argenziano,
  • Adithya Kannan,
  • Aayushi Mahajan,
  • Julia Furnari,
  • Fahad Paryani,
  • Deborah Boyett,
  • Akshay Save,
  • Nelson Humala,
  • Fatima Khan,
  • Juncheng Li,
  • Hong Lu,
  • Yu Sun,
  • John F. Tuddenham,
  • Alexander R. Goldberg,
  • Athanassios Dovas,
  • Matei A. Banu,
  • Tejaswi Sudhakar,
  • Erin Bush,
  • Andrew B. Lassman,
  • Guy M. McKhann,
  • Brian J. A. Gill,
  • Brett Youngerman,
  • Michael B. Sisti,
  • Jeffrey N. Bruce,
  • Peter A. Sims,
  • Vilas Menon,
  • Peter Canoll

DOI
https://doi.org/10.1038/s41467-023-38186-1
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 18

Abstract

Read online

Abstract Glioblastoma (GBM) diffusely infiltrates the brain and intermingles with non-neoplastic brain cells, including astrocytes, neurons and microglia/myeloid cells. This complex mixture of cell types forms the biological context for therapeutic response and tumor recurrence. We used single-nucleus RNA sequencing and spatial transcriptomics to determine the cellular composition and transcriptional states in primary and recurrent glioma and identified three compositional ‘tissue-states’ defined by cohabitation patterns between specific subpopulations of neoplastic and non-neoplastic brain cells. These tissue-states correlated with radiographic, histopathologic, and prognostic features and were enriched in distinct metabolic pathways. Fatty acid biosynthesis was enriched in the tissue-state defined by the cohabitation of astrocyte-like/mesenchymal glioma cells, reactive astrocytes, and macrophages, and was associated with recurrent GBM and shorter survival. Treating acute slices of GBM with a fatty acid synthesis inhibitor depleted the transcriptional signature of this pernicious tissue-state. These findings point to therapies that target interdependencies in the GBM microenvironment.